NCT00024440
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Genta Incorporated Berkeley Heights, New Jersey, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,057 public trials
2,038 recruiting studies
Lymphoproliferative Disorders trial results
NCT00017602
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Genta Incorporated Berkeley Heights, New Jersey, United States
Completed
A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
NCT01068301
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +25 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT00217789
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +4 more
- Locations
-
- University of Medicine and Dentistry of New Jersey Newark, New Jersey, United States
NCT00656812
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Universitätsklinikum Graz Graz, Austria
- Universitaetsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria
- Krankenhaus der Stadt Linz Linz, Austria
- Universitaetsklinik f. Innere Medizin III Salzburg, Austria
Completed
Lymphoma Follow-up
NCT00744120
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- NIA Clinical Research Unit Baltimore, Maryland, United States
NCT00071955
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
- Rush Cancer Institute at Rush University Medical Center Chicago, Illinois, United States
- Indiana University Cancer Center Indianapolis, Indiana, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00040950
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
Completed
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
NCT00040690
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
- Locations
-
- Medical Research Council Clinical Trials Unit London, England, United Kingdom
Completed
Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
NCT00053092
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia
- Derriford Hospital Plymouth, England, United Kingdom